Potential therapeutic targets can be identified by comprehending the molecular interactions and pathways impacted by genetic differences. Subsequent investigations may delve into developing focused treatments intended to reinstate or adjust the disturbed associations between PKCι and Par-6, which could potentially impact cellular polarity, the EMT, and the advancement of cancer [41, 47]. The gene discussed is PRKCI; the disease is cancer.